downtoearth-subscribe

Iressa hopes turn sour for AstraZeneca

Iressa was supposed to be the dream drug for advanced lung cancer patients and its developer, AstraZeneca. Known as a molecular targeting drug, which pinpoints and attacks cancer cells, Iressa